Lymphoid and myeloid lineage segregation is a major developmental step during early hematopoiesis from hematopoietic stem cells. It is not clear, however, whether multipotent progenitors (MPPs) adopt a lymphoid or myeloid fate through stochastic mechanisms, or whether this process can be regulated by extracellular stimuli. Here we show that lymphoid lineage specification occurs in MPPs prior to lymphoid lineage priming, during which MPPs migrate from the proximal to the distal region relative to the endosteum of the bone marrow.
Introduction
Hematopoietic stem cells (HSCs) can give rise to all classes of hematopoietic cells, which are categorized into two major groups, lymphoid and myeloid lineages 1 . Lymphoid lineage cells, or lymphocytes, include T, B, and NK cells.
Other hematopoietic cell types, such as megakaryocytes and erythrocytes (MegE), as well as granulocytes and macrophages (GM) belong to the myeloid lineage 1 . The major divergence of lymphoid and myeloid lineages occurs at the multipotent progenitor (MPP) stage 2, 3 . However, regulatory mechanisms of this lineage choice by MPPs are not clear. Figure 1A ) 2, 4 . Characterization of these three MPP subsets indicates a sequential loss of MegE and GM lineage differentiation potential prior to lymphoid lineage commitment at the CLP stage in the bone marrow or DN3 stage in the thymus [3] [4] [5] [6] . Gene expression analysis of MPPs indicated that these uncommitted progenitors have already initiated the expression of several lymphoid and myeloid lineage specific genes 4, 7, 8 . Such promiscuous expression of lineage specific genes prior to lineage commitment is known as lineage priming, a phenomenon thought to be involved in maintaining the plasticity of the differentiation potential of MPPs [9] [10] [11] . Although precise mechanisms are not completely understood, G-protein coupled receptors (GPCRs), such as chemokine receptors expressed on hematopoietic progenitors play a critical role in the regulating the localization and interaction between hematopoietic progenitors and bone marrow stromal cells 14 . In particular, chemokine receptor CXCR4 and its ligand SDF1 are indispensable for the retention of HSCs in the bone marrow and/or formation of the HSC niche in adult mice [15] [16] [17] . In addition to chemokine receptors, other types of GPCRs also critically regulate the localization of hematopoietic cells. For example, sphingosine-1-phosphate (S1P) receptor 1 (S1PR1) is indispensable for the egress of single positive thymocytes from thymus to the periphery 18 . 
Materials and Methods

Mice
C57Bl/Ka-Thy1.1 (CD45.2), C57Bl/Ka-Thy1.1-Ly5.1 (CD45.1), and C57Bl/KaThy1.1 (CD45.1/CD45.2) mice were used as wild type (WT) mice 4 . β-actin GFP transgenic mice (GFP mice) and RAG1/GFP knock-in (KI) mice 19 , both of which are on C57Bl/Ka-Thy1.1 background were also used. All studies and procedures were approved by the Duke University Animal Care and Use Committee. .
FACS, in vitro
Gene expression analysis in MPP subsets
Quantitative RT-PCR analysis of lymphoid and myeloid specific gene expression was performed as previously described 
PTX treatment and in vivo homing of MPPs
To investigate the role of GPCRs on MPPs, we purified 5x10 4 VCAM-1 + and VCAM-1 -MPPs from GFP mice, incubated the cells at 37˚C for 2 hrs in RPMI1640 with 10% FCS in the presence or absence of PTX (100 ng/ml) and injected the cells intravenously into irradiated (920 rads) or non-irradiated WT For personal use only. on September 24, 2017. by guest www.bloodjournal.org From mice. To examine the location of MPPs in the bone marrow, we removed femurs from the host mice at 48 hrs after injection. GMPs were purified from GFP mice using cell surface markers as previously described 22 . When examining the homing capacity of VCAM-1-RAG1
-and VCAM-1-RAG1 + MPPs, the cells were purified from RAG1/GFP KI mice and incubated with 0.5 nM CFSE for 10 min at 37˚C prior to injection into recipient mice. The bones were fixed with 1%
paraformaldehyde and embedded in OCT medium. Longitudinal cryostat sections (5 μm thick) were stained with DAPI and the image under a fluorescence microscope (Zeiss) was captured with a CCD camera.
Results
Lymphoid lineage specification occurs prior to lymphoid lineage priming.
RAG1 is one of the earliest known lymphoid related genes up-regulated in Since VCAM-1 -MPPs preferentially give rise to lymphocytes, but still retain some myeloid differentiation potential ( Figure 1A ) 2, 4 , we asked whether the GM differentiation potential in this population is enriched in the RAG1 Figure 1E ). These results suggest that most VCAM-1 -MPPs are lymphoid specified in vivo regardless of their RAG1
priming status or intrinsic GM differentiation ability.
GM-CSF is dispensable for GM lineage commitment in vivo, even though GM-CSF is one of the major cytokines that support GM colony formation by bone marrow cells in in vitro cultures 23, 24 . However, if GM-CSF is available, hematopoietic progenitors with GM-CSF receptors may be actively instructed to differentiate towards the GM lineage by GM-CSF stimulation 20 . In fact, the MPPs, although also lymphoid specified, lacked lymphoid related gene expression ( Figure 2B ). In addition, we did not observe any down-modulation of myeloid related genes such as GM-CSFRα and C/EBPα in lymphoid specified VCAM-1 -RAG1 -MPPs (Figure 2A ). Upon the onset of lymphoid priming in VCAM-1 -RAG1 + MPPs, however, GM related genes became down-regulated and silenced upon further differentiation to CLPs (Figure 2A) , where lymphoid lineage commitment is established. VCAM-1 -RAG1 -MPPs, which had low in vivo and high in vitro GM potential ( Figures 1C and 1D 
VCAM-1 -RAG1 -MPPs regain in vivo GM potential by PTX treatment.
The existence of specialized niches for HSCs and B cell progenitors in the bone marrow has been demonstrated 14, 25 . The discrepancy between in vitro and in vivo myeloid differentiation potential of VCAM-1 -RAG1 -MPPs led us to hypothesize that these lymphoid specified MPPs are localized in a microenvironment in which the cue to initiate myeloid differentiation and/or production of myeloid growth factors are defective. The lack of myeloid stimuli, in turn, leads to preferential differentiation into lymphocytes from MPPs. We reason that if lymphoid specified VCAM-1 -RAG1 -(and VCAM-1 -RAG1 + ) MPPs are localized in a distinct microenvironment, it is likely that they are recruited there and home to this "niche" through a GPCR-dependent manner similar to the regulatory mechanisms of organogenesis of various organs 26 or differential T and B cell localization in the spleen 27, 28 . To test this hypothesis, we evaluated the GM differentiation potential of VCAM-1 -MPPs treated with PTX, which can uncouple GPCR signaling by inhibiting the interaction of GPCRs with G-proteins 29 .
In this experiment, we purified VCAM-1 -MPPs from enhanced GFP transgenic mice (simply GFP mice hereafter) and injected them into host so that we could detect donor-derived cells in a highly sensitive manner 
Discussions
Several studies in recent years suggested a role for extrinsic factors in influencing cell fate decisions in hematopoietic progenitors 20, 33 . However, the role of cytokines or other extrinsic factors in influencing lymphoid vs. myeloid lineage differentiation has remained unclear. Our study here provides evidence that the bone marrow microenvironment does play a critical role in lineage diversification from MPPs toward the lymphoid and myeloid lineages. The results of this study and our previous studies suggest that the myeloid developmental program seems to be dominant over the lymphoid differentiation program 20, 34 .
Therefore, lack of stimulation that leads HSCs and MPPs to myeloid lineage might be prerequisite for lymphoid lineage priming and commitment.
Nonetheless, the findings in this study do not address whether certain extrinsic factors instruct MPPs towards the myeloid lineage or simply play a supportive role like many other myeloid growth factors [35] [36] [37] . Recently, we demonstrated that the MEK/ERK pathway plays an important role in myeloid differentiation, most likely at the onset of myeloid lineage commitment during hematopoiesis 34 . This suggests that extracellular stimuli are necessary for proper myeloid cell development from HSCs. Our data suggest that most GMPs are located at the endosteal region in the bone marrow ( Figure 4D ), implying that the endosteal region includes HSC and myeloid niches.
Heterogeneity of bone marrow stromal cells has been suggested because of the difference in phenotype, cytokine production pattern, and ability to support hemato/lymphopoiesis 38 . However, unlike the spleen, which has well defined For personal use only. on September 24, 2017 . by guest www.bloodjournal.org From structures, such as red/white pulps and periarterial lymphatic sheath (PALS, known as the T cell zone) and can be identified by simple hematoxylin & eosin staining of the sections, little is known about the structure of the bone marrow 30 .
Scadden and colleagues recently demonstrated that HSCs locate more proximal to the endosteal region than more mature hematopoietic progenitors by using live imaging techniques 39 . Li's group showed that proximal localization of HSCs to the endosteum is enhanced in irradiated mice but not evident in non-irradiated mice 32 . In this study, we simply divided the central marrow region, which is the rest of the distinctive endosteal region 30 , into outer half (outer region) and inner half (inner region), and found that the majority of VCAM-1 -MPPs localized at the inner region ( Figures 4C and 4D) . Therefore, unique distribution patterns of bone marrow stromal cells that preferentially support lymphoid and myeloid specification and commitment might be present in the bone marrow ( Figure 5 ).
Thus, it is important in the future to identify bone marrow stromal cells that produce the extrinsic factors responsible for supporting myeloid differentiation.
In conclusion, the results in this paper provide important insights into the regulatory mechanisms of how lymphoid specification is determined at the next issue to address is to determine which GPCR(s) are involved in homing lymphoid specified progenitors to their specialized microenvironment. Since other bacteria components such as cholera toxin also targets the function of GPCRs, it will be interesting to see whether treatment of MPPs with cholera toxin also affect to their preferential localization in the bone marrow. These experiments, along with gene expression profiling of MPP subsets and characterization of bone marrow microenvironments, will help to narrow down the types of GPCRs involved in the homing process of lymphoid specified progenitors. These next studies will be a key in advancing our understanding of lymphocyte development in adults at the earliest stage. 
